GADD45A and neoplasm: That both of these genes were up-regulated after priming treatment and only to a lower (CDKN1A) or no (GADD45A) degree suggests a strong involvement of the p53 pathway in the cellular tumor response to a priming treatment with 177Lu-octreotate.